NEW YORK (GenomeWeb News) – Gen-Probe said today that it has inked an agreement to distribute Life Technologies' SeCore Human Leukocyte Antigen Sequence-Based Typing kits for use with the 3500 Dx Genetic Analyzer.

Under the agreement, Gen-Probe's LifeCodes business unit will have co-exclusive rights to sell the SeCore SBT line in the transplant market alongside Life Technologies' HLA sales force in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.